Bulletin from the extraordinary general meeting in EQL Pharma AB on 10 December 2021
Today, on 10 December 2021, an extraordinary general meeting was held in EQL Pharma AB. In light of the ongoing Covid-19 pandemic and in order to reduce the risk of infection spreading, the meeting was held only by advance voting (postal vote) in accordance with temporary legislation. A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority of votes.Resolution on implementation of a long-term incentive program The meeting resolved in accordance with the proposal from the board of directors to implement a long-term incentive program for